Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anticoagulant Therapy
Dalteparin doesn't influence lupus anticoagulant test results
June 17th, 2005
Dalteparin therapy is unlikely to influence the results of lupus anticoagulant (LA) assays. "Treatment with unfractionated heparin is known to affect screening tests" for LA, hematologists in Norway explained. "False positive test results are common because confirmatory steps lack sufficient specificity to distinguish between LA and the presence of heparin." In a recent study, S. Liestol and coauthors at Ullevaal University Hospital sought to determine "if therapeutic levels of low-molecular weight heparin (LMWH) may cause false positive tests for LA or alter the LA test results in LA-positive patients." "We also wanted to...
Source: Drug Week (2005-06-17)
|
